Disease flares during temporary interruption of ibrutinib therapy in patients with chronic lymphocytic leukemia

被引：0
|
作者：
Hampel, Paul [1 ]
Call, Timothy [2 ]
Rabe, Kari [2 ]
Ding, Wei [2 ]
Muchtar, Eli [2 ]
Kenderian, Saad [2 ]
Leis, Jose [2 ]
Witzig, Thomas [2 ]
Koehler, Amber [2 ]
Fonder, Amie [2 ]
Schwager, Susan [2 ]
Van Dyke, Daniel [2 ]
Slager, Susan [2 ]
Kay, Neil [2 ]
Parikh, Sameer [2 ]
机构：
[1] Mayo Clin, Sch Grad Med Educ, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
来源：
LEUKEMIA & LYMPHOMA | 2020年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2117
引用
收藏
页码：204 / 206
页数：3
相关论文
共 50 条
  • [1] Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia
    Hampel, Paul J.
    Call, Timothy G.
    Rabe, Kari G.
    Ding, Wei
    Muchtar, Eli
    Kenderian, Saad S.
    Wang, Yucai
    Leis, Jose F.
    Witzig, Thomas E.
    Koehler, Amber B.
    Fonder, Amie L.
    Schwager, Susan M.
    Van Dyke, Daniel L.
    Braggio, Esteban
    Slager, Susan L.
    Kay, Neil E.
    Parikh, Sameer A.
    ONCOLOGIST, 2020, 25 (11): : 974 - 980
  • [2] Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib
    Hampel, Paul J.
    Cherng, Hua-Jay J.
    Call, Timothy G.
    Ding, Wei
    Khanlari, Mahsa
    McPhail, Ellen D.
    Miranda, Roberto N.
    Lin, Pei
    Tawbi, Hussein A.
    Ferrajoli, Alessandra
    Wierda, William G.
    Jain, Nitin
    Parikh, Sameer A.
    BLOOD ADVANCES, 2020, 4 (18) : 4508 - 4511
  • [3] Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL)
    Wright, Nicholas
    Voshtina, Ensi
    George, Gemlyn
    Singavi, Arun
    Field, Joshua
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (06) : 751 - 755
  • [4] Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL)
    Nicholas Wright
    Ensi Voshtina
    Gemlyn George
    Arun Singavi
    Joshua Field
    International Journal of Hematology, 2019, 110 : 751 - 755
  • [5] The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice
    Parikh, Sameer A.
    Achenbach, Sara J.
    Call, Timothy G.
    Rabe, Kari G.
    Ding, Wei
    Leis, Jose F.
    Kenderian, Saad S.
    Chanan-Khan, Asher A.
    Koehler, Amber B.
    Schwager, Susan M.
    Muchtar, Eli
    Fonder, Amie L.
    McCullough, Kristen B.
    Nedved, Adrienne N.
    Smith, Matthew D.
    Slager, Susan L.
    Kay, Neil E.
    Finnes, Heidi D.
    Shanafelt, Tait D.
    CANCER MEDICINE, 2020, 9 (10): : 3390 - 3399
  • [6] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
    Burger, J. A.
    Tedeschi, A.
    Barr, P. M.
    Robak, T.
    Owen, C.
    Ghia, P.
    Bairey, O.
    Hillmen, P.
    Bartlett, N. L.
    Li, J.
    Simpson, D.
    Grosicki, S.
    Devereux, S.
    McCarthy, H.
    Coutre, S.
    Quach, H.
    Gaidano, G.
    Maslyak, Z.
    Stevens, D. A.
    Janssens, A.
    Offner, F.
    Mayer, J.
    O'Dwyer, M.
    Hellmann, A.
    Schuh, A.
    Siddiqi, T.
    Polliack, A.
    Tam, C. S.
    Suri, D.
    Cheng, M.
    Clow, F.
    Styles, L.
    James, D. F.
    Kipps, T. J.
    Keating, Michael
    Jen, Jie
    Jindra, Pavel
    Simkovic, Martin
    Braester, Andrei
    Ruchlemer, Rosa
    Foa, Roberto
    Semenzato, Gianpietro
    Hawkins, Timothy
    Atanasio, Carolina Moreno
    Demirkan, Fatih
    Kaynar, Leylagul
    Pylypenko, Halyna
    Fox, Christopher
    Thirman, Michael
    Campbell, Philip
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2425 - 2437
  • [7] NAIL AND HAIR CHANGES DURING IBRUTINIB THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
    Mauro, F. R.
    Porrazzo, M.
    Bottoni, U.
    Riemma, C.
    Raponi, S.
    Guarini, A.
    Foa, R.
    HAEMATOLOGICA, 2017, 102 : 122 - 122
  • [8] Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy
    Serhat Çelik
    Leylagül Kaynar
    Zeynep Tuğba Güven
    Mustafa Baydar
    Muzaffer Keklik
    Mustafa Çetin
    Ali Ünal
    Fatih Demirkan
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 282 - 289
  • [9] Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
    Maddocks, Kami J.
    Ruppert, Amy S.
    Lozanski, Gerard
    Heerema, Nyla A.
    Zhao, Weiqiang
    Abruzzo, Lynne
    Lozanski, Arletta
    Davis, Melanie
    Gordon, Amber
    Smith, Lisa L.
    Mantel, Rose
    Jones, Jeffrey A.
    Flynn, Joseph M.
    Jaglowski, Samantha M.
    Andritsos, Leslie A.
    Awan, Farrukh
    Blum, Kristie A.
    Grever, Michael R.
    Johnson, Amy J.
    Byrd, John C.
    Woyach, Jennifer A.
    JAMA ONCOLOGY, 2015, 1 (01) : 80 - 87
  • [10] Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy
    celik, Serhat
    Kaynar, Leylagul
    Guven, Zeynep Tugba
    Baydar, Mustafa
    Keklik, Muzaffer
    cetin, Mustafa
    Unal, Ali
    Demirkan, Fatih
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (02) : 282 - 289
12345